Back to Quadrature Capital Ltd Quadrature Capital Ltd

AMLXAMLX

5 quarters

Position history for Quadrature Capital LtdQuadrature Capital Ltd's holdings in Amylyx Pharmaceuticals, Inc.

No. Quadrature Capital exited its AMLX (Amylyx Pharmaceuticals) position in Q1 2026. Its Q4 2025 13F listed 15,465 shares worth $186,817. Quadrature Capital first reported AMLX in Q1 2025 and held it in 4 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$44,986

Total Shares Change

-12,744

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$13.90
0
2025-Q4
Decreased
15,465
-45.3%
$186,8170.0%$12.08
0
2025-Q3
Decreased
28,286
-3.9%
$384,1240.0%$13.59
0
2025-Q2
Increased
29,430
+130.9%
$188,3520.0%$6.41
37
2025-Q1
New
12,744
—
$44,9860.0%$3.66
28

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used